Ondansetron

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ondansetron and local guidelines before prescribing.

5-HT3 antagonist

Mechanism

5-HT3 receptor antagonist.

Uses

Chemotherapy and postoperative nausea and vomiting, hyperemesis (selected).

Dosing

Side effects

Constipation, headache, QT prolongation, flushing.

Interactions

QT-prolonging drugs; apomorphine contraindicated.

Contraindications and cautions

Congenital long QT, apomorphine

Monitoring

ECG

Pregnancy and breastfeeding

Avoid in first trimester

Renal and hepatic impairment

Reduce dose in severe liver impairment

Overdose and reversal

Supportive

Special advice

Check electrolytes and ECG in cardiac risk; avoid in congenital long QT.

More from the textbook: uses, cautions and other points
Where it is discussed in the book